Human MYRF/11orf9/C11orf9 ORF/cDNA clone-Lentivirus plasmid (NM_013279.4)

Cat. No.: pGMLV002051
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human MYRF/11orf9/C11orf9 Lentiviral expression plasmid for MYRF lentivirus packaging, MYRF lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to MYRF/11orf9 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1634.4
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLV002051
Gene Name MYRF
Accession Number NM_013279.4
Gene ID 745
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 3336 bp
Gene Alias 11orf9,C11orf9,CUGS,MMERV,MRF,Ndt80,pqn-47
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 1xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGCACTGGCTTCCAGCAGGCCACGACATCAACGGTGCCCTGGAGCCCTCCAACATAGACACCAGCATCCTGGAGGAGTACATCAGCAAGGAGGATGCCTCCGACCTCTGCTTCCCTGACATCTCTGCTCCAGCCAGCTCGGCCTCCTACTCCCACGGGCAGCCTGCGATGCCTGGCTCCAGCGGGGTCCACCACCTGAGCCCCCCTGGGGGTGGACCCTCCCCGGGGCGCCATGGTCCCCTCCCACCCCCGGGCTACGGCACCCCGCTGAACTGCAACAACAACAACGGCATGGGCGCTGCCCCCAAGCCCTTCCCGGGGGGCACCGGGCCCCCCATCAAGGCTGAGCCCAAGGCTCCCTATGCCCCAGGCACACTGCCGGACTCTCCCCCAGACTCGGGCTCCGAGGCCTACTCCCCCCAGCAGGTGAATGAGCCCCACCTCCTGCGCACGATAACCCCTGAGACACTGTGCCACGTGGGAGTGCCCTCCCGCCTGGAGCATCCGCCCCCACCTCCAGCCCACTTGCCAGGCCCCCCGCCACCCCCACCACCCCCACCTCACTACCCTGTCCTGCAGCGGGATCTGTACATGAAGGCCGAGCCCCCGATCCCCCACTACGCTGCCATGGGGCAGGGGCTGGTGCCCACTGATCTTCACCACACCCAGCAGTCCCAGATGCTGCACCAGCTCCTGCAGCAGCACGGAGCTGAGCTCCCTACACACCCCTCCAAGAAGAGGAAGCACTCTGAATCCCCCCCCAGCACCCTCAATGCCCAGATGCTGAATGGAATGATCAAACAGGAGCCTGGGACCGTGACAGCCCTGCCTCTGCACCCCACTCGAGCCCCATCGCCACCCTGGCCTCCCCAGGGTCCGCTCTCCCCGGGCCCTGGTTCCTTGCCTCTCAGCATTGCCCGTGTCCAGACACCGCCTTGGCACCCGCCAGGTGCCCCCTCCCCAGGCCTCCTGCAGGACAGTGACAGCCTCAGTGGCTCCTACCTGGACCCCAACTACCAGTCCATCAAGTGGCAGCCTCATCAGCAGAACAAGTGGGCGACCCTGTACGATGCTAACTACAAGGAGCTGCCCATGCTCACCTACCGCGTGGATGCGGACAAGGGCTTCAACTTTTCGGTGGGCGACGACGCCTTTGTGTGCCAGAAGAAGAACCACTTCCAGGTGACAGTGTACATCGGCATGCTGGGCGAGCCCAAGTACGTCAAGACGCCCGAGGGCCTCAAGCCCCTCGACTGCTTCTATCTGAAGCTGCACGGAGTGAAGCTGGAGGCCCTGAACCAGTCCATTAACATCGAGCAGTCCCAGTCAGACCGGAGCAAGCGGCCCTTCAACCCGGTCACGGTCAATCTGCCCCCTGAGCAGGTCACGAAGGTGACTGTGGGGCGGCTGCACTTCAGCGAGACCACCGCTAACAACATGCGTAAGAAGGGCAAGCCCAACCCGGACCAGAGGTACTTCATGCTGGTGGTGGCCCTCCAGGCTCATGCACAGAACCAGAACTACACGCTGGCCGCCCAGATCTCAGAGCGCATCATTGTGCGGGCCTCCAACCCAGGCCAGTTCGAGAGCGACAGCGATGTGTTGTGGCAGCGGGCACAGGTGCCCGACACCGTCTTCCACCACGGCCGCGTGGGCATCAACACAGACCGGCCGGATGAGGCGCTGGTTGTGCACGGGAATGTCAAGGTCATGGGCTCGCTTATGCACCCCTCCGACCTGCGCGCCAAGGAACACGTGCAGGAGGTGGACACCACCGAGCAATTGAAGAGGATCTCGCGCATGCGGCTGGTGCACTACAGATACAAGCCCGAGTTCGCCGCCAGCGCGGGCATCGAGGCCACCGCGCCAGAGACAGGTGTCATCGCTCAGGAGGTGAAGGAGATCTTGCCTGAGGCTGTGAAAGACACCGGAGACATGGTCTTTGCCAATGGGAAAACCATAGAGAACTTCCTGGTGGTGAACAAGGAGCGCATCTTCATGGAGAACGTAGGGGCCGTGAAGGAGCTGTGCAAGCTGACAGACAACCTGGAGACGCGCATTGATGAGCTGGAGCGCTGGAGCCACAAGCTGGCCAAGCTGCGGCGGCTCGACAGCCTCAAGTCCACCGGCAGCTCGGGCGCCTTCAGCCATGCAGGGAGCCAGTTCAGTCGGGCGGGCAGCGTCCCCCACAAGAAGAGGCCCCCCAAGGTGGCCAGCAAGTCATCGTCCGTGGTTCCGGACCAGGCCTGCATCAGCCAGCGCTTCCTGCAGGGAACCATCATTGCCCTGGTGGTGGTCATGGCCTTCAGCGTGGTGTCCATGTCCACACTGTACGTGCTGAGCCTGCGCACAGAGGAGGACCTGGTAGACACTGATGGCAGGTCCAGCCAGAGCTTTGGGACCACGCAGCTCCGACAGTCCCCCTTGACCACGGGGCTACCAGGCATACAGCCCTCTTTGCTGCTGGTGACCACCAGCCTCACCAGCTCGGCCCCAGGTTCTGCTGTCCGCACCTTGGACATGTGTTCCAGCCACCCCTGCCCTGTCATCTGCTGTTCCTCACCCACTACCAACCCTACCACTGGTCCTAGTCTTGGCCCCAGCTTTAACCCTGGCCATGTTCTCAGCCCAAGTCCCAGCCCCAGCACCAACCGCTCAGGCCCCAGCCAGATGGCCCTTCTGCCAGTCACCAACATCAGAGCCAAGTCCTGGGGTCTTTCAGTCAATGGCATTGGCCACTCCAAGCATCACAAGAGTCTGGAGCCTCTGGCCAGCCCTGCAGTCCCCTTCCCTGGGGGGCAGGGCAAAGCCAAGAACAGTCCCAGCCTTGGTTTCCATGGCCGGGCCCGCCGAGGGGCCCTCCAGTCCAGCGTGGGCCCTGCTGAGCCCACCTGGGCCCAGGGCCAGTCAGAGCCAGTGCCCTCCCTGACCTCCATCCAGGTGCTGGAGAATTCGATGTCCATCACCTCCCAGTACTGTGCTCCAGGGGATGCCTGCAGGCCTGGGAACTTCACCTACCACATCCCTGTCAGTAGTGGCACCCCACTGCACCTCAGCCTGACTCTGCAGATGAACTCCTCCTCCCCCGTGTCTGTGGTGCTGTGCAGCCTGAGGTCAAAGGAGGAACCATGTGAGGAGGGGAGCCTTCCACAGAGTCTCCACACCCACCAGGACACCCAGGGCACCTCTCACCGGTGGCCAATAACCATCCTGTCCTTCCGTGAATTCACCTACCACTTCCGGGTGGCACTGCTGGGTCAGGCCAACTGCAGTTCAGAGGCTCTCGCCCAGCCAGCCACAGACTACCACTTCCACTTCTACCGCCTGTGTGACTGA
ORF Protein Sequence MHWLPAGHDINGALEPSNIDTSILEEYISKEDASDLCFPDISAPASSASYSHGQPAMPGSSGVHHLSPPGGGPSPGRHGPLPPPGYGTPLNCNNNNGMGAAPKPFPGGTGPPIKAEPKAPYAPGTLPDSPPDSGSEAYSPQQVNEPHLLRTITPETLCHVGVPSRLEHPPPPPAHLPGPPPPPPPPPHYPVLQRDLYMKAEPPIPHYAAMGQGLVPTDLHHTQQSQMLHQLLQQHGAELPTHPSKKRKHSESPPSTLNAQMLNGMIKQEPGTVTALPLHPTRAPSPPWPPQGPLSPGPGSLPLSIARVQTPPWHPPGAPSPGLLQDSDSLSGSYLDPNYQSIKWQPHQQNKWATLYDANYKELPMLTYRVDADKGFNFSVGDDAFVCQKKNHFQVTVYIGMLGEPKYVKTPEGLKPLDCFYLKLHGVKLEALNQSINIEQSQSDRSKRPFNPVTVNLPPEQVTKVTVGRLHFSETTANNMRKKGKPNPDQRYFMLVVALQAHAQNQNYTLAAQISERIIVRASNPGQFESDSDVLWQRAQVPDTVFHHGRVGINTDRPDEALVVHGNVKVMGSLMHPSDLRAKEHVQEVDTTEQLKRISRMRLVHYRYKPEFAASAGIEATAPETGVIAQEVKEILPEAVKDTGDMVFANGKTIENFLVVNKERIFMENVGAVKELCKLTDNLETRIDELERWSHKLAKLRRLDSLKSTGSSGAFSHAGSQFSRAGSVPHKKRPPKVASKSSSVVPDQACISQRFLQGTIIALVVVMAFSVVSMSTLYVLSLRTEEDLVDTDGRSSQSFGTTQLRQSPLTTGLPGIQPSLLLVTTSLTSSAPGSAVRTLDMCSSHPCPVICCSSPTTNPTTGPSLGPSFNPGHVLSPSPSPSTNRSGPSQMALLPVTNIRAKSWGLSVNGIGHSKHHKSLEPLASPAVPFPGGQGKAKNSPSLGFHGRARRGALQSSVGPAEPTWAQGQSEPVPSLTSIQVLENSMSITSQYCAPGDACRPGNFTYHIPVSSGTPLHLSLTLQMNSSSPVSVVLCSLRSKEEPCEEGSLPQSLHTHQDTQGTSHRWPITILSFREFTYHFRVALLGQANCSSEALAQPATDYHFHFYRLCD

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP1229-Ab Anti-MYRF monoclonal antibody
    Target Antigen GM-Tg-g-IP1229-Ag MYRF protein
    ORF Viral Vector pGMLV002051 Human MYRF Lentivirus plasmid
    ORF Viral Vector vGMLV002051 Human MYRF Lentivirus particle


    Target information

    Target ID GM-IP1229
    Target Name MYRF
    Gene ID 745, 225908, 719083, 293736, 101083206, 483794, 509704, 100059805
    Gene Symbol and Synonyms 11orf9,6030439E18,C11orf9,C14H11orf9,C18H11orf9,C29H11orf9,CD1H11orf9,CUGS,Gm1804,Gm98,MMERV,MRF,MYRF,Ndt80,pqn-47,RGD1306622
    Uniprot Accession Q9Y2G1
    Uniprot Entry Name MYRF_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000124920
    Target Classification Not Available

    This gene encodes a transcription factor that is required for central nervous system myelination and may regulate oligodendrocyte differentiation. It is thought to act by increasing the expression of genes that effect myelin production but may also directly promote myelin gene expression. Loss of a similar gene in mouse models results in severe demyelination. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.